SYBX.US Synlogic Inc

Healthcare Biotechnology USA Stocks
1.10 USD
Close of Nov 17, 2026
0.5401 1.73
Market cap
USD 13.5M
P/E
-
P/B
1.12x
ROE
-48.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SYBX.US undervalued?

Graham number

The Graham number of Synlogic Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Synlogic Inc fundamental analysis

No fundamental analysis for Synlogic Inc yet.

Synlogic Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Synlogic Inc

Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.

Full company profile